Enhanced External Counterpulsation (EECP) therapy is a non-invasive treatment that helps improve blood flow to the heart and relieve symptoms of angina and heart failure.

EECP therapy uses inflatable cuffs wrapped around the legs to compress and decompress the blood vessels, promoting increased blood flow to the heart during the relaxation phase of the heartbeat.

Patients with chronic stable angina, heart failure, or those who are not suitable candidates for invasive procedures like angioplasty or bypass surgery may benefit from EECP therapy.

EECP therapy can help reduce angina symptoms, improve exercise tolerance, enhance the quality of life, and decrease the need for medication in some patients.

Each EECP session typically lasts about one hour and is usually conducted five days a week for a total of seven weeks.

The APPT (Activated Partial Thromboplastin Time) test measures the time it takes for blood to clot, evaluating the functionality of clotting factors in the blood.

It is crucial for diagnosing bleeding disorders, monitoring anticoagulant therapy, and assessing clotting function before surgery.

No special preparation is usually needed. Inform your healthcare provider about any medications or supplements you are taking.

Results are generally available within a few hours to 1 day after the test.

The test helps diagnose bleeding disorders such as hemophilia, monitor anticoagulant therapy, and assess clotting function for surgical evaluation.

Lumpectomy preserves more of the breast tissue, while mastectomy involves removing the entire breast. Both have similar long-term survival rates for early-stage breast cancer.